Merck KGaA
XMUN:MRK
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Merck KGaA
XMUN:MRK
|
DE |
Intrinsic Value
The intrinsic value of 
Merck KGaA (MRK) under the Base Case is 115.91 EUR per share.
Compared with the current market price of 150.95 EUR, the stock appears
Overvalued by 23% .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Merck KGaA Does
Merck KGaA is a German science and technology company that makes medicines, lab tools, and specialty materials. Its healthcare business sells prescription drugs and treatments, especially in cancer, fertility, and neurology. Its life science business sells chemicals, testing products, and equipment that researchers and drugmakers use in labs and factories.
- Headquarters
- Germany DE
- Employees
- 62 461
- IPO date
- Oct 20, 1995
Merck KGaA has no economic moat
Competing medicines and alternative suppliers leave Merck KGaA without dependable protection across its businesses. Its patents and established customer relationships protect some products, but do not provide a lasting barrier around the whole company.
Read the full moat analysis
Revenue & Expenses Breakdown
Merck KGaA
Earnings Waterfall
Merck KGaA
The intrinsic value for Merck KGaA (MRK) under the Base Case is 115.91 EUR.
Compared with the current market price of 150.95 EUR, the stock appears Overvalued by 23% .